It has been shown that DAPK1 activation triggers aberrant tau phosphorylation in AD and stroke 12, 16, while whether DAPK1 and Pin1 also participate in Aβ species-induced tau dysregulation remains to be determined. The gene discussed is MAPT; the disease is Alzheimer disease.